Back to results
US 2012/0225045 A1Published application
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
AssigneeOncolytics Biotech Inc.
InventorsDonald Morris, Bradley G. Thompson, Matthew C. Coffey
Life of this patent
Estimating the term…
Abstract
Reovirus can be used to selectively remove ras-mediated neoplastic cells from a cellular composition. It is of particular interest to purge autographs which may contain neoplastic cells with reovirus before transplanting the autographs back into the recipient, thereby reducing the risk of introducing or reintroducing neoplastic cells into the recipient.
Claims24
1-24. (canceled)
A cellular composition for transplantation, wherein the cellular composition has been treated with a reovirus to remove neoplastic cells.
Dependencies are inferred from the claim text.